Literature DB >> 8479130

Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases.

T Takemura1, K Yoshioka, N Aya, K Murakami, A Matumoto, H Itakura, T Kodama, H Suzuki, S Maki.   

Abstract

This study offers morphological evidence of the involvement of lipid abnormalities in human glomerular injury. Renal biopsy tissues from patients with several types of glomerular diseases were immunocytochemically examined using antibodies to apolipoproteins (apo) A-I, B-100, and E, and antibodies to low density lipoprotein (LDL) receptors and scavenger receptors. Immunofluorescent staining showed the predominant deposition of apo B and apo E in the mesangial area in mesangial proliferative types of glomerulonephritis; the distribution and staining intensity of these apolipoproteins correlated with the grade of mesangial proliferation and proteinuria, but were independent of plasma lipid levels. Immunoelectron microscopy revealed that apo B and apo E were distributed in droplets within glomerular epithelial and mesangial cells or in a granular pattern in the expanded mesangial matrix. Apo A-I was mainly localized in the visceral epithelial cells of normal human kidneys. Staining for apo A-I was increased in the glomerular epithelial cells of nephritic kidneys, compared to the pattern in normal human kidneys, and was decreased in the sclerosed areas of glomeruli. An immunogold technique revealed the expression of LDL receptors on the surface membranes of glomerular mesangial and epithelial cells. Dual immunofluorescent staining showed that apo B and LDL receptors were occasionally co-localized in nephritic glomeruli. Scavenger receptor was detected on the plasma membranes of mesangial and visceral epithelial cells. The glomerular expression of scavenger receptor was increased in glomeruli with marked mesangial proliferation. In addition, the expression of this receptor was intense in monocytes/macrophages occasionally infiltrating the glomeruli. Our present findings indicate that in human nephritic kidneys, glomerular epithelial and mesangial cells express both LDL receptors and scavenger receptors. The accumulation of apolipoproteins, whether receptor-mediated or mediated by other mechanisms, can occur independently of plasma lipid levels, and may be associated with mesangial expansion and proteinuria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479130     DOI: 10.1038/ki.1993.129

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

Review 1.  Lipids and diabetic nephropathy.

Authors:  Rey F Rosario; Sharma Prabhakar
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 2.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  Extracellular matrix and the kidney.

Authors:  P N Furness
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 4.  Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.

Authors:  Jacek Rysz; Anna Gluba-Brzózka; Maciej Banach; Andrzej Więcek
Journal:  Int Urol Nephrol       Date:  2015-03-11       Impact factor: 2.370

5.  Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A).

Authors:  K Nakajou; S Horiuchi; M Sakai; N Haraguchi; M Tanaka; M Takeya; M Otagiri
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

6.  Low density lipoprotein enhances the cellular action of arginine vasopressin in rat glomerular mesangial cells in culture.

Authors:  S Ishikawa; M Kawasumi; K Okada; T Saito
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice.

Authors:  Deepa Taneja; Joel Thompson; Patricia Wilson; Katie Brandewie; Liliana Schaefer; Bonnie Mitchell; Lisa R Tannock
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

Review 8.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

9.  Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

Authors:  Hyun Ju Kim; Hamid Moradi; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08

10.  Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case-control study.

Authors:  Manouchehr Nakhjavani; Alireza Esteghamati; Omid Khalilzadeh; Firouzeh Asgarani; Nasrin Mansournia; Mehrshad Abbasi
Journal:  Int Urol Nephrol       Date:  2009-09-19       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.